Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma

PaperCitations, authors & open-access status

Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 10 citations, 2021 year and closed oa status.

10
Citations
2021
Year
closed
OA Status

Related on ScholarIQ

Christian Karime
Author
Expert Opinion on Investigational Drugs
Journal
Immune Response and Inflammation
Topic
Immune Response and Inflammation
Topic
Immune cells in cancer
Topic
Immunotherapy and Immune Responses
Topic
470M+ articles · free account